Clinical Series - Drug Dosing Obese Patients
Drug doses often warrant adjustment in obese patients. Clinicians should consider the patient’s body composition when calculating doses as drug clearance is greater in obesity and correlates with lean body weight. Body size metrics help guide dose selection, but there are advantages and disadvantages to all of them as chronic dosing using total body weight can lead to drug toxicity.
- Describe physiological changes with obesity and how this could affect PK/PD of drugs
- Describe different body size descriptors
- Recognise common drugs needing dose adjustment in obesity.
This webinar commences at 1.00pm AEDT
Please note registration for this webinar will close at 12.30pm AEDT on 14 March 2018.
* You will receive a confirmation email upon completion of your registration. If you do not receive a confirmation email, you have not completed your registration and your space is not guaranteed. Please contact the secretariat by emailing email@example.com.
- Dr Michael Barras, BPharm GradDipClinPharm PhD, Princess Alexandra Hospital, Qld
- Amy Legg, Bpharm GradDipClinPharm, Advanced Clinical Pharmacist, Royal Brisbane and Women's Hospital, Qld
The program addresses the following pharmacy competency standards:
- 3.1 Develop a patient-centred, culturally responsive approach to medication management
- 3.2 Implement the medication management strategy or plan
(National Competency Standards Framework for Pharmacists in Australia, 2016)
This webinar has been accredited for 1 hour of Group-1 (or 1 CPD credit) The accreditation number is S2018/11.